Prognosis depends on the histology, tumor burden, stage, age, performance status, treatment type. The five-year failure-free survival rate is 91 percent, in patients with limited-stage (IE, IIE) disease who received combined modality (chemotherapy and radiotherapy) treatment, implying an excellent prognosis for thyroid lymphoma in general.